Current and historical daily PE Ratio for Sensus Healthcare Inc (
) from 2020 to Jun 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sensus Healthcare stock (FRA:5TX) PE ratio as of Jun 23 2024 is 18.03.
More Details
Sensus Healthcare Inc (FRA:5TX) PE Ratio (TTM) Chart
Sensus Healthcare Inc (FRA:5TX) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 949
- 1
- 2
- 3
- 4
- 5
- 6
- 11
Sensus Healthcare PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-23 | 18.0 | 2024-04-19 | 11.5 |
2024-06-21 | 18.0 | 2024-04-18 | 11.4 |
2024-06-20 | 17.8 | 2024-04-17 | 11.2 |
2024-06-19 | 17.8 | 2024-04-16 | 11.3 |
2024-06-18 | 18.0 | 2024-04-15 | 11.8 |
2024-06-17 | 18.3 | 2024-04-12 | 10.9 |
2024-06-14 | 18.7 | 2024-04-11 | 11.6 |
2024-06-13 | 18.7 | 2024-04-10 | 12.1 |
2024-06-12 | 19.8 | 2024-04-09 | 12.4 |
2024-06-11 | 18.9 | 2024-04-08 | 11.7 |
2024-06-10 | 19.1 | 2024-04-05 | 11.8 |
2024-06-07 | 20.8 | 2024-04-04 | 12.2 |
2024-06-06 | 19.6 | 2024-04-03 | 11.9 |
2024-06-05 | 18.8 | 2024-04-02 | 13.1 |
2024-06-04 | 18.7 | 2024-03-28 | 13.4 |
2024-06-03 | 18.6 | 2024-03-27 | 150.8 |
2024-05-31 | 19.4 | 2024-03-26 | 142.3 |
2024-05-30 | 19.3 | 2024-03-25 | 141.3 |
2024-05-29 | 18.4 | 2024-03-22 | 144.1 |
2024-05-28 | 20.9 | 2024-03-21 | 137.5 |
2024-05-27 | 20.9 | 2024-03-20 | 145.3 |
2024-05-24 | 20.4 | 2024-03-19 | 136.7 |
2024-05-23 | 20.2 | 2024-03-18 | 130.6 |
2024-05-22 | 20.4 | 2024-03-15 | 138.8 |
2024-05-21 | 21.5 | 2024-03-14 | 145.9 |
2024-05-20 | 20.4 | 2024-03-13 | 140.6 |
2024-05-17 | 22.1 | 2024-03-12 | 128.3 |
2024-05-16 | 20.9 | 2024-03-11 | 155.7 |
2024-05-15 | 18.2 | 2024-03-08 | 151.6 |
2024-05-14 | 17.7 | 2024-03-07 | 152.3 |
2024-05-13 | 18.3 | 2024-03-06 | 152.9 |
2024-05-10 | 18.2 | 2024-03-05 | 154.3 |
2024-05-09 | 13.2 | 2024-03-04 | 156.3 |
2024-05-08 | 13.1 | 2024-03-01 | 155.8 |
2024-05-07 | 13.1 | 2024-02-29 | 169.3 |
2024-05-06 | 12.7 | 2024-02-28 | 173.3 |
2024-05-03 | 13.4 | 2024-02-27 | 173.3 |
2024-05-02 | 12.4 | 2024-02-26 | 183.1 |
2024-04-30 | 11.8 | 2024-02-23 | 178.6 |
2024-04-29 | 12.0 | 2024-02-22 | 178.4 |
2024-04-26 | 11.8 | 2024-02-21 | 185.4 |
2024-04-25 | 11.3 | 2024-02-20 | 178.2 |
2024-04-24 | 11.8 | 2024-02-19 | 178.6 |
2024-04-23 | 11.9 | 2024-02-16 | 163.8 |
2024-04-22 | 11.5 | 2024-02-15 | 163.6 |
Sensus Healthcare Inc (FRA:5TX) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Sensus Healthcare Inc Sensus Healthcare Inc logo](https://static.gurufocus.com/logos/0C0000B2H6.png?14)
Sensus Healthcare Inc
NAICS : 339112
SIC : 3841
ISIN : US81728J1097
Description
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.